Last edition
News about "Peptide Manufacturing"
The rise of GLP-1 therapies has transformed diabetes and obesity treatment. Following semaglutide patent expiry in India in March 2026, multiple companies entered the market simultaneously. Pharma Industrial India spoke with industry leaders about the opportunities, challenges, and future of this rapidly evolving therapeutic segment.
Peptide Manufacturing | 26/06/2026 | By Akanki
Neuland Laboratories partnership with LIR Life Sciences Corp will focus on developing and manufacturing cell-penetrating peptides to support LIR Life’s patch-based GLP-1/GIP obesity treatment platform.
Peptide Manufacturing | 07/05/2026 | By News Bureau | 171
WuXi STA adds peptide manufacturing capacity at Changzhou campus
With two new 2,000L reactors the total reactor volume of the Solid Phase Peptide Synthesizers at WuXi TIDES has increased to over 10,000 litres
Peptide Manufacturing | 08/05/2023 | By Sudeep Soparkar | 936
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy